Operti M - Search Results

1

Translating the Manufacture of Immunotherapeutic PLGA Nanoparticles from Lab to Industrial Scale: Process Transfer and In Vitro Testing.

Operti MC, Bernhardt A, Pots J, Sincari V, Jager E, Grimm S, Engel A, Benedikt A, Hrubý M, De Vries IJM, Figdor CG, Tagit O. Operti MC, et al. Pharmaceutics. 2022 Aug 13;14(8):1690. doi: 10.3390/pharmaceutics14081690. Pharmaceutics. 2022. PMID: 36015316 Free PMC article.

2

Clinical and molecular characterization of patients affected by Beckwith-Wiedemann spectrum conceived through assisted reproduction techniques.

Carli D, Operti M, Russo S, Cocchi G, Milani D, Leoni C, Prada E, Melis D, Falco M, Spina J, Uliana V, Sara O, Sirchia F, Tarani L, Macchiaiolo M, Cerrato F, Sparago A, Pignata L, Tannorella P, Cardaropoli S, Bartuli A, Riccio A, Ferrero GB, Mussa A. Carli D, et al. Among authors: operti m. Clin Genet. 2022 Oct;102(4):314-323. doi: 10.1111/cge.14193. Epub 2022 Jul 21. Clin Genet. 2022. PMID: 35842840 Free PMC article.

3

Industrial Scale Manufacturing and Downstream Processing of PLGA-Based Nanomedicines Suitable for Fully Continuous Operation.

Operti MC, Bernhardt A, Sincari V, Jager E, Grimm S, Engel A, Hruby M, Figdor CG, Tagit O. Operti MC, et al. Pharmaceutics. 2022 Jan 25;14(2):276. doi: 10.3390/pharmaceutics14020276. Pharmaceutics. 2022. PMID: 35214009 Free PMC article.

4

PLGA-based nanomedicines manufacturing: Technologies overview and challenges in industrial scale-up.

Operti MC, Bernhardt A, Grimm S, Engel A, Figdor CG, Tagit O. Operti MC, et al. Int J Pharm. 2021 Aug 10;605:120807. doi: 10.1016/j.ijpharm.2021.120807. Epub 2021 Jun 16. Int J Pharm. 2021. PMID: 34144133 Free article. Review.

5

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles.

Operti MC, Dölen Y, Keulen J, van Dinther EAW, Figdor CG, Tagit O. Operti MC, et al. Pharmaceutics. 2019 Nov 8;11(11):590. doi: 10.3390/pharmaceutics11110590. Pharmaceutics. 2019. PMID: 31717354 Free PMC article.

6

A comparative assessment of continuous production techniques to generate sub-micron size PLGA particles.

Operti MC, Fecher D, van Dinther EAW, Grimm S, Jaber R, Figdor CG, Tagit O. Operti MC, et al. Int J Pharm. 2018 Oct 25;550(1-2):140-148. doi: 10.1016/j.ijpharm.2018.08.044. Epub 2018 Aug 23. Int J Pharm. 2018. PMID: 30144511

7

Muscle purine nucleotide cycle enzymes in exercise intolerance.

Operti MG, Vincent MF, Brucher JM, Van den Berghe G. Operti MG, et al. Adv Exp Med Biol. 1998;431:205-9. doi: 10.1007/978-1-4615-5381-6_40. Adv Exp Med Biol. 1998. PMID: 9598060 No abstract available.

8

Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance.

Operti MG, Vincent MF, Brucher JM, van den Berghe G. Operti MG, et al. Muscle Nerve. 1998 Mar;21(3):401-3. doi: 10.1002/(sici)1097-4598(199803)21:3<401::aid-mus16>3.0.co;2-1. Muscle Nerve. 1998. PMID: 9486871

9

Relationships between trehalose metabolism and maltose utilization in Saccharomyces cerevisiae : III. Evidence for alternative pathways of trehalose synthesis.

Operti MS, Oliveira DE, Freitas-Valle AB, Oestreicher EG, Mattoon JR, Panek AD. Operti MS, et al. Curr Genet. 1982 May;5(1):69-76. doi: 10.1007/BF00445744. Curr Genet. 1982. PMID: 24186091

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters